Search Results for keywords:"consent order"

Found 3 results
Skip to main content

Search Results: keywords:"consent order"

  • Type:Notice
    Citation:86 FR 1497
    Reading Time:about 16 minutes

    The Federal Trade Commission has proposed a consent agreement with Chemence, Inc. to address allegations of deceptive practices related to their claims about products being "Made in USA." The FTC found that Chemence falsely advertised their glue products as primarily made in the United States, while much of the materials were sourced from abroad. The proposed order includes a $1.2 million judgment and guidelines for future advertising and compliance measures, including preventing Chemence from making false claims about product origins unless they accurately reflect manufacturing and material sources. This action is part of a shift towards stricter enforcement of "Made in USA" claims, aiming to protect consumers and honest competitors.

    Simple Explanation

    Chemence, Inc. got in trouble for not telling the truth about where their glue was made. They said it was mostly made in the USA, but it wasn't, and now they have to pay a big fine and promise to be honest in the future.

  • Type:Notice
    Citation:90 FR 9723
    Reading Time:about 29 minutes

    The Federal Trade Commission (FTC) has proposed a consent order to address alleged anticompetitive practices by the private equity firm Welsh, Carson, Anderson & Stowe. The firm was accused of violating several federal laws by consolidating anesthesia services in Texas through its company, U.S. Anesthesia Partners, Inc., which led to increased prices. The proposed order seeks to limit Welsh Carson's influence over this company and requires them to obtain FTC approval for future acquisitions in anesthesia and related medical fields to prevent similar monopolistic behavior. The public has until March 20, 2025, to submit comments on this proposed consent order.

    Simple Explanation

    The FTC wants to make sure a company called Welsh, Carson, Anderson & Stowe doesn't make it too expensive for people to get anesthesia in Texas. They are asking people to share their thoughts about new rules to stop the company from becoming too powerful in hospitals.

  • Type:Notice
    Citation:89 FR 96996
    Reading Time:about 49 minutes

    The Federal Trade Commission (FTC) has announced a proposed consent order with Mobilewalla Inc., a data broker accused of unlawfully collecting and selling consumers' sensitive location information without obtaining proper consent. The company allegedly violated multiple parts of the FTC Act by collecting and retaining precise location data and targeting consumers based on characteristics revealed by their location history, such as religion or medical conditions. The proposed order aims to restrict Mobilewalla's future data practices, mandating they verify consumer consent and avoid retaining sensitive data indefinitely. The public is invited to comment on this order until January 6, 2025, before the FTC makes a final decision.

    Simple Explanation

    The FTC is telling Mobilewalla that they can't secretly collect and sell people's private location details anymore. People can share what they think about this rule until January 6, 2025.